India’s pharmaceutical market continued its strong growth trajectory in March 2026, expanding 10.7% year-on-year, driven largely by rising demand for treatments targeting chronic conditions. According to data from IQVIA and Equirus Securities, diseases such as hypertension, diabetes and high cholesterol now account for over 40% of the total market, reflecting a steady Continue Reading




